Metraipolis › archive › dc_1725d4e750fb

Multiple Bone Metastases From Non-Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case Report — Europe PMC PMID:41458054

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41458054
DOI
10.1002/iju5.70119
License (as archived)
solo-consultazione
Archived
2026-11-07T10:05:35.726Z
SHA-256 of the archived text
5c9aecb24592e4c53d6b46529ba49ab099af47e3f3709749a60a785bb81ac024
Stable URL of this page
https://metraipolis.com/documento/dc_1725d4e750fb

How to cite

Multiple Bone Metastases From Non-Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case Report — Europe PMC PMID:41458054 — Europe PMC (en), https://europepmc.org/article/MED/41458054 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1725d4e750fb (Metraipolis archive dc_1725d4e750fb, sha256 5c9aecb24592e4c53d6b46529ba49ab099af47e3f3709749a60a785bb81ac024)
BibTeX
@misc{dc1725d4e750fb,
  title = {Multiple Bone Metastases From Non-Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case Report — Europe PMC PMID:41458054},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41458054},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1725d4e750fb; sha256 5c9aecb24592e4c53d6b46529ba49ab099af47e3f3709749a60a785bb81ac024},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41458054. Agents can read the archived copy with the MCP tool read_document.